Discovery of the first orally bioavailable GLI1 PROTAC for the treatment of colorectal cancer. // European Journal of Medicinal Chemistry. – URL: https://www.sciencedirect.com/science/article/pii/S0223523426009256?dgcid=rss_sd_all
Discovery of the first orally bioavailable GLI1 PROTAC for the treatment of colorectal cancer. European Journal of Medicinal Chemistry. https://www.sciencedirect.com/science/article/pii/S0223523426009256?dgcid=rss_sd_all
“Discovery of the first orally bioavailable GLI1 PROTAC for the treatment of colorectal cancer.” European Journal of Medicinal Chemistry.
@article{article74093,
title = {Discovery of the first orally bioavailable GLI1 PROTAC for the treatment of colorectal cancer},
journal = {European Journal of Medicinal Chemistry},
url = {https://www.sciencedirect.com/science/article/pii/S0223523426009256?dgcid=rss_sd_all}
}
ABSTRACT Singlet oxygen ( 1 O 2 ) is increasingly recognized as a key reactive species in advanced oxidation processes (AOPs) due to its long lifetime, wide pH tolerance, and selective oxidation behaviours toward electron‑rich organic...
ABSTRACT The Truce–Smiles rearrangement (TSR) is a versatile synthetic strategy for carbon–carbon bond formation without the need of metal catalysis. The key step is formation of spiro‐Meisenheimer complex which typically undergoes the...